Mechanistic Resolution
The molecular-biology era. Chromatin interaction, gene-expression modulation, telomerase regulation. International peer-reviewed replication across Italy, South Korea, and the United Kingdom.
From phenomenon to mechanism.
The third era brought the modern molecular-biology toolkit to bioregulator research — and with it, the resolution of the mechanism that had been observed but not explained for decades. Studies across this period demonstrated that short peptide bioregulators translocate to the cell nucleus, bind specific DNA sequences within gene-promoter regions, and modulate gene expression directly at the transcriptional level.
Telomerase regulation, chromatin-state modulation, and tissue-specific transcriptomic effects were resolved in parallel, establishing the bioregulator class as a mechanistically distinct therapeutic category — neither hormone nor classical receptor ligand, but a regulatory molecule operating at the level of gene expression itself.
Independent peer-reviewed replication.
During this era, independent replication and extension by research groups in Italy, South Korea, and the United Kingdom established the body of international peer-reviewed literature that anchors the discipline today. Each program contributed distinct methodological strengths — Italian molecular biology, Korean transcriptomic and chromatin-immunoprecipitation methodology, and U.K. clinical-observational and longevity-program evidence — and collectively converged on a unified mechanistic picture.
The era closed with bioregulator research established as a mechanistically resolved, internationally replicated therapeutic class — awaiting only its formal disciplinary codification and its translation into modern non-injectable therapeutic formats.